09-10-2018 05:13 PM CET - Health & Medicine
Print

Global Cancer Immunotherapy Market 2018-2025 Analysis By Treatment Studies With Key Competitors Pfizer, AstraZeneca, Bristol Mayers Squibb, IGNITE Immunotherapy, Western Oncolytics Ltd, Targovax, Therapeutics Inc., NewLink Genetics, Ziopharm Oncology

Press release from: Data Bridge Market Research
Global Cancer Immunotherapy Market – Industry Trends and Forecast to 2025
Global Cancer Immunotherapy Market – Industry Trends and Forecast to 2025
This report on the Cancer Immunotherapy Market place offers explanatory expertise available on the market parts like dominating players, manufacturing, sales, intake, import and export, and the simplest improvement in the corporation size, deployment kind, inside, segmentation comprised at some point of this analysis, additionally foremost the players have used various techniques such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others, to boom their footprints on this marketplace in order to sustain in long term, moreover to the existing the clean perspective of Cancer Immunotherapy Market.

The Global Cancer Immunotherapy Market is expected to reach USD 202.89 Billion by 2025, from USD 70.63 billion in 2017 growing at a CAGR of 14.1% during the forecast period of 2018 to 2025.  In September 2017 Merck receives the FDA accelerated approval for pembrolizumab for the treatment of advanced gastric cancer Biothera Pharmaceuticals announces the clinical trial collaboration with Genentech part of F.Hoffman La. Roche Ltd. The global cancer immunotherapy market size was valued at USD 40.7 billion in 2016.

Download PDF sample copy of this research report@ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

The global Cancer immunotherapy Market evokes the immune response against the cancerous cells. Immunotherapy acts by targeting CTLA-4 and PD-1/PD-L1 Pathway. It works either by slowing down the growth of cancer cells or boosts the immune system to destroy the cancerous cells or either it stops the cancer from spreading to other parts of the body. This global Cancer immunotherapy Market report defines the market trends and forecast the upcoming opportunities and threats of the cancer immunotherapy market in the next 8 years.

Major competitors/ Company Profiles

Some of the major players operating in the Global Cancer Immunotherapy Market are-

Top Competitors:

Pfizer Inc,
Astrazeneca,
Hoffmann-La Roche LTd,
Bayer AG,
Amgen Inc,
Novartis AG,
Bristol Mayers Squibb,
Johnson and Johnson,
Merck KgaA,
Eli Lilly,
celgene Corp,
Gilead ,
bluebird bio Inc,
Celldex therapeutics,
SillaJen Inc,
IGNITE Immunotherapy,
Westeren oncolytics ltd,
PsiOxus Therapeutics,
MultiVir,
Vyriad,
Oncolys BioPharma Inc,
Cold genesys Inc,
Sorrento Therapeutics Inc,
Targovax,
Lokon therapeutics,
New-link genetics Corporation,
Ziopharma oncology,
Tessa therapeutics Pte Ltd,
Atara biotherapeutics,
Cellectis,
Oryx,
VCN Biosciences,
Orca Therapeutics B.V,
Daiichi Sankyo Co Ltd,
Ascend laboratories LLC, 
Transgene SA,
among others.

 In 2011, Amgen Inc acquired biovex with USD 1 Billion which was into the oncolytic virus immunotherapy development. 

In October 2016, Genetech subsidiary of Roche received the approval for atezolizumab for the treatment of non-small cell lung cancer

In March 2017, Serono Inc received the FDA accelerated approval for avelumab for the treatment of metastatic merkell cell carcinoma.

To Avail 10% Discount On This Report Mail Us on:- sopan.gedam@databridgemarketresearch.com

Table of Contents:

• 1. Introduction
• 2. Market Segmentation
• 3. Market Overview
• 4. Executive Summary
• 5. Premium Insights
• 6. Global, By Component
• 7. Product/Service Type
• 8. Delivery
• 9. Industry Type
• 10. Geography
• 10.1. Overview
• 10.2. North America
• 10.3. Europe
• 10.4. Asia-Pacific
• 10.5. South America
• 10.6. Middle East & Africa
• 11. Company Landscape
• 12. Company Profiles
• 13. Related Reports

Major Market Drivers and Restraints:

New technologies and combination product availability is expected to drive the market in the forecast period.
Production of biosimilars and biobetters.
Rising cancer suffering population.
Increased investment in research and development of cancer immunotherapy.
Downward pricing pressure owing to its commodity nature.

Market Segmentation:

The Global Cancer Immunotherapy Market Is Segmented-

By Product Type 
Monoclonal Antibody
Immunomodulatory
Cell Therapies
Checkpoint Inhibitors
Vaccines
By Cancer Type
Lung Cancer
Melanoma
Breast Cancer
Head And Neck Cancer
Prostate Cancer
Colorectal Cancer
Multiple Myeloma
By End Users
By Geography 

Based On Geography, The Global Cancer Immunotherapy Market Report Covers Data Points For 28 Countries Across Multiple Geographies Namely North America & South America, Europe, Asia-Pacific And, Middle East & Africa. Some Of The Major Countries Covered In This Report Are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa And, Brazil Among Others.

Reason to buy the Report:

It helps to know that the Global Cancer Immunotherapy Market product sections along with their future forecast.
It aids for making informed business decisions by utilizing a comprehensive analysis of market sections and from having whole insights of Cancer Immunotherapy Market.
It poses a forward-looking prospect on distinct facets controlling and Global Cancer Immunotherapy Market

This poses a six-year Global Cancer Immunotherapy Market forecast assessment primarily based mostly on the way the sectors are anticipated.
Global Cancer Immunotherapy market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Customization Options

All segmentation provided above in this report is represented at country level and can be customized according to needs.
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization).

Inquire Regarding This Report @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1230952 • Views: 322
More releasesMore releases

You can edit or delete your press release here: